Document is current
Any future updates will be listed below
-
Authors
Sella, Tal
Gelber, Shari I.
Poorvu, Philip D.
Kim, Hee-Jeong
Dominici, Laura
Guzman-Arocho, Yaileen D.
Collins, Laura
Ruddy, Kathryn J.
Tamimi, Rulla M.
Peppercorn, Jeffrey M.
Schapira, Lidia
Borges, Virginia F.
Come, Steven E.
Warner, Ellen
Snow, Craig
Jakubowski, Debbie M.
Russell, Christy A.
Winer, Eric P.
Rosenberg, Shoshana M.
Partridge, Ann H. https://orcid.org/0000-0002-4722-4824
- License Information
-
More Information
Article History
Received: 3 October 2020
Accepted: 20 October 2020
First Online: 4 November 2020
Compliance with ethical standards
:
: T. Sella reports honorarium from Roche. P.D. Poorvu reports honoraria from Medscape for peer review of educational materials on breast cancer. HJ Kim declares that she has no conflict of interest. L Dominici declares that she has no conflict of interest. Y.D. Guzman-Arocho declares that she has no conflict of interest. L. Collins declares that she has no conflict of interest. K.J. Ruddy reports stock and other ownership interests in Merck and Pfizer; and patents, royalties, other intellectual property for her spouse: he is a co-inventor of technology licensed by Mayo Clinic to AliveCor (MountainView, CA), which makes a smartphone-enabled remote ECG monitoring system. R.M. Tamimi declares that he/she has no conflict of interest. J.M. Peppercorn reports employment with GlaxoSmithKline; stock and other ownership interests in GlaxoSmithKline; consulting or advisory role for Athenex; and research funding from Pfizer. L. Schapira reports consulting or advisory role for Bluenote Therapeutics and Rubedo. V.F. Borges reports consulting or advisory role for Seattle Genetics; and institutional research funding from Abbott/AbbVie, Millennium and Seattle Genetics. S.E. Come reports research funding from AstraZeneca. E. Warner reports travel, accommodations and expenses from Novartis. C. Snow declares that she has no conflict of interest. D.M. Jakubowski reports employment with Genomic Health, Inc. and stock and other ownership interests in Genomic Health, Inc. C.A. Russell reports employment with Exact Sciences/Genomic Health International; stock and other ownership interests in Genomic Health International; honoraria from Genentech/Roche, Genomic Health, Novartis and Pfizer; Speakers’ Bureau from Genentech/Roche, Genomic Health, Novartis and Pfizer; and travel, accommodations and expenses from Genentech/Roche, Genomic Health, Novartis and Pfizer. E.P. Winer reports stock and other ownership interests in Verastem; honoraria from Genentech/Roche and Genomic Health; consulting or advisory role for Carrick Therapeutics, G1 Therapeutics, Genomic Health, GlaxoSmithKline, Jounce Therapeutics, Leap Therapeutics, Lilly and Seattle Genetics; and institutional research funding from Genentech and Novartis. S.M. Rosenberg reports stock and other ownership interests in Cantel Medical and Edwards Lifesciences. A.H. Partridge reports patents, royalties, and other intellectual property (self): I receive small royalty payments for co-authoring the breast cancer survivorship section of UpToDate; and travel, accommodations and expenses from Novartis.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
